RAD18
Basic information
Region (hg38): 3:8775402-8963773
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAD18 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 39 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 1 | 0 |
Variants in RAD18
This is a list of pathogenic ClinVar variants found in the RAD18 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-8881361-T-G | not specified | Uncertain significance (Nov 13, 2024) | ||
3-8881404-C-T | not specified | Uncertain significance (Jun 12, 2023) | ||
3-8890449-G-C | not specified | Uncertain significance (Oct 22, 2024) | ||
3-8898936-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
3-8898951-G-C | not specified | Uncertain significance (Apr 12, 2023) | ||
3-8898987-G-A | not specified | Uncertain significance (Apr 13, 2022) | ||
3-8902409-G-C | not specified | Uncertain significance (Dec 26, 2023) | ||
3-8902415-T-A | not specified | Uncertain significance (Aug 02, 2021) | ||
3-8902447-C-A | not specified | Uncertain significance (Dec 04, 2024) | ||
3-8902448-A-T | not specified | Uncertain significance (Oct 06, 2024) | ||
3-8902455-C-A | not specified | Uncertain significance (Jun 01, 2023) | ||
3-8902476-T-C | not specified | Uncertain significance (Aug 02, 2021) | ||
3-8913652-T-G | not specified | Uncertain significance (Nov 21, 2024) | ||
3-8913670-G-C | not specified | Uncertain significance (Nov 14, 2023) | ||
3-8935927-T-A | not specified | Uncertain significance (Jul 15, 2021) | ||
3-8935992-T-G | not specified | Uncertain significance (Aug 15, 2024) | ||
3-8935999-C-T | not specified | Uncertain significance (May 27, 2022) | ||
3-8936000-G-T | not specified | Uncertain significance (Aug 15, 2024) | ||
3-8936035-G-A | Likely benign (Feb 01, 2023) | |||
3-8939582-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
3-8939636-C-T | not specified | Uncertain significance (Dec 20, 2022) | ||
3-8941470-T-C | not specified | Uncertain significance (Dec 03, 2024) | ||
3-8941499-G-A | not specified | Conflicting classifications of pathogenicity (Sep 08, 2024) | ||
3-8941540-C-G | not specified | Uncertain significance (Apr 19, 2024) | ||
3-8941553-C-T | not specified | Uncertain significance (Nov 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RAD18 | protein_coding | protein_coding | ENST00000264926 | 13 | 188370 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.58e-8 | 0.842 | 125662 | 0 | 86 | 125748 | 0.000342 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.135 | 267 | 261 | 1.02 | 0.0000139 | 3261 |
Missense in Polyphen | 56 | 68.562 | 0.81678 | 864 | ||
Synonymous | -0.394 | 93 | 88.3 | 1.05 | 0.00000464 | 878 |
Loss of Function | 1.60 | 16 | 24.5 | 0.652 | 0.00000112 | 350 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000236 | 0.000211 |
Ashkenazi Jewish | 0.000496 | 0.000496 |
East Asian | 0.000376 | 0.000326 |
Finnish | 0.000614 | 0.000601 |
European (Non-Finnish) | 0.000326 | 0.000316 |
Middle Eastern | 0.000376 | 0.000326 |
South Asian | 0.000768 | 0.000621 |
Other | 0.000336 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase involved in postreplication repair of UV-damaged DNA. Postreplication repair functions in gap- filling of a daughter strand on replication of damaged DNA. Associates to the E2 ubiquitin conjugating enzyme UBE2B to form the UBE2B-RAD18 ubiquitin ligase complex involved in mono- ubiquitination of DNA-associated PCNA on 'Lys-164'. Has ssDNA binding activity. {ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:21659603}.;
- Pathway
- DNA Repair;Post-translational protein modification;Metabolism of proteins;Recognition of DNA damage by PCNA-containing replication complex;Protein ubiquitination;DNA Damage Bypass;E3 ubiquitin ligases ubiquitinate target proteins
(Consensus)
Recessive Scores
- pRec
- 0.0799
Intolerance Scores
- loftool
- 0.634
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.31
Haploinsufficiency Scores
- pHI
- 0.252
- hipred
- Y
- hipred_score
- 0.565
- ghis
- 0.613
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.957
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rad18
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- DNA repair;postreplication repair;protein monoubiquitination;cellular response to DNA damage stimulus;response to UV;protein ubiquitination;DNA damage response, detection of DNA damage;protein autoubiquitination;positive regulation of chromosome segregation;negative regulation of cell death
- Cellular component
- nucleus;nucleoplasm;replication fork;cytoplasm;centrosome;nuclear body;site of double-strand break;nuclear inclusion body;Rad6-Rad18 complex
- Molecular function
- Y-form DNA binding;damaged DNA binding;single-stranded DNA binding;protein binding;polyubiquitin modification-dependent protein binding;ubiquitin protein ligase binding;identical protein binding;single-stranded DNA-dependent ATPase activity;protein-containing complex binding;metal ion binding;ubiquitin protein ligase activity